CRGX | CARGO Therapeutics, Inc. Common Stock Annual &

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021
Total Assets	453.03 Million	10.24 Million	4.5 Million
Total Current Assets	409.47 Million	3.92 Million	184 Thousand
Cash And Short Term Investments	405.73 Million	1.87 Million	41 Thousand
Cash and Cash Equivalents	405.73 Million	1.87 Million	41 Thousand
Short Term Investments	-	-	-
Net Receivables	1.73 Million	476 Thousand	-
Inventory	-	-	-
Other Current Assets	2 Million	1.57 Million	143 Thousand
Total Non-Current Assets	43.55 Million	6.31 Million	4.32 Million
Net PPE	38.6 Million	5.53 Million	3.87 Million
Good Will And Intangible Assets	-	-	-
Good Will	-	-	-
Intangible Assets	-	-	-
Long-Term Investments	567 Thousand	-	-
Tax Assets	-	-	-
Other Non Current Assets	4.39 Million	783 Thousand	442 Thousand
Other Assets	-	-	-
Total Liabilities	47.65 Million	45.47 Million	4.67 Million
Total Current Liabilities	21.16 Million	44.13 Million	2.44 Million
Account Payables	5.01 Million	3.48 Million	818 Thousand
Tax Payables	-	-	-
Short Term Debt	2.27 Million	22.91 Million	938 Thousand
Deferred Revenue	12.84 Million	4.65 Million	593 Thousand
Other Current Liabilities	1.03 Million	13.08 Million	100 Thousand
Total Non Current Liabilities	26.48 Million	1.34 Million	2.23 Million
Long-Term Debt	26.26 Million	1.09 Million	2.23 Million
Deferred Revenue Non Current	-	-	-
Deferred Tax Liabilities Non Current	-	-	-
Other Non Current Liabilities	225 Thousand	250 Thousand	-
Other Liabilities	-	-	-
Total Equity	405.38 Million	-35.23 Million	-175 Thousand
Stock Holders Equity	405.38 Million	-35.23 Million	-175 Thousand
Common Stock	41 Thousand	15 Thousand	11 Thousand
Retained Earnings	-145.14 Million	-46.99 Million	-6.04 Million
Accumulated other comprehensive income	-453.03 Million	-	-
Common Stock Equity	405.38 Million	-35.23 Million	-175 Thousand
Capital Lease Obligation	28.54 Million	2.09 Million	3.16 Million
Total Investments	567 Thousand	-	-
Total Debt	28.54 Million	24 Million	3.16 Million
Net Debt	-377.19 Million	22.13 Million	3.12 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	490.01 Million	422.42 Million	453.03 Million	453.03 Million	82.41 Million	60.49 Million
Total Current Assets	448.09 Million	379.94 Million	409.47 Million	409.47 Million	63.41 Million	46.73 Million
Cash And Short Term Investments	443.47 Million	375.91 Million	405.73 Million	405.73 Million	60.34 Million	42.37 Million
Cash and Cash Equivalents	153.58 Million	81.52 Million	405.73 Million	405.73 Million	60.34 Million	42.37 Million
Short Term Investments	289.89 Million	294.38 Million	-	-	-	-
Net Receivables	2.51 Million	2.42 Million	1.73 Million	1.73 Million	475 Thousand	475 Thousand
Inventory	-	-	-	-	-	1.87 Million
Other Current Assets	2.1 Million	1.61 Million	2 Million	2 Million	2.59 Million	2.01 Million
Total Non-Current Assets	41.91 Million	42.48 Million	43.55 Million	43.55 Million	18.99 Million	13.75 Million
Net PPE	36.97 Million	37.53 Million	38.6 Million	38.6 Million	11.97 Million	9.32 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	567 Thousand	567 Thousand	567 Thousand	567 Thousand	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	4.37 Million	4.38 Million	4.39 Million	4.39 Million	7.02 Million	4.43 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	53.91 Million	49.21 Million	47.65 Million	47.65 Million	191.74 Million	135.47 Million
Total Current Liabilities	26.42 Million	22.64 Million	21.16 Million	21.16 Million	41.13 Million	28.1 Million
Account Payables	7 Million	7.16 Million	5.01 Million	5.01 Million	7.43 Million	5.82 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	649 Thousand	1.63 Million	2.27 Million	2.27 Million	2.59 Million	2.49 Million
Deferred Revenue	-	12.29 Million	12.84 Million	12.84 Million	12.4 Million	8.72 Million
Other Current Liabilities	18.76 Million	1.55 Million	1.03 Million	1.03 Million	18.71 Million	11.06 Million
Total Non Current Liabilities	27.48 Million	26.56 Million	26.48 Million	26.48 Million	150.61 Million	107.36 Million
Long-Term Debt	27.48 Million	26.56 Million	26.26 Million	26.26 Million	300 Thousand	978 Thousand
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-1.00	-	225 Thousand	225 Thousand	150.31 Million	106.39 Million
Other Liabilities	1.00	-	-	-	-	-
Total Equity	436.1 Million	373.21 Million	405.38 Million	405.38 Million	-109.33 Million	-74.97 Million
Stock Holders Equity	436.1 Million	373.21 Million	405.38 Million	405.38 Million	-109.33 Million	-74.97 Million
Common Stock	46 Thousand	39 Thousand	41 Thousand	41 Thousand	1000.00	15 Thousand
Retained Earnings	-225.3 Million	-180.95 Million	-145.14 Million	-145.14 Million	-113.06 Million	-77.59 Million
Accumulated other comprehensive income	-323 Thousand	-279 Thousand	-	-453.03 Million	-150.08 Million	-
Common Stock Equity	436.1 Million	373.21 Million	405.38 Million	405.38 Million	-109.33 Million	-74.97 Million
Capital Lease Obligation	27.48 Million	28.2 Million	28.54 Million	28.54 Million	2.89 Million	3.47 Million
Total Investments	290.46 Million	294.38 Million	567 Thousand	567 Thousand	-	-
Total Debt	28.13 Million	28.2 Million	28.54 Million	28.54 Million	2.89 Million	3.47 Million
Net Debt	-125.44 Million	-53.32 Million	-377.19 Million	-377.19 Million	-57.45 Million	-38.89 Million

Balance Sheet Charts

Hexima Limited

HXL

Full Analysis

Annual Balance Sheets
Sesen Bio, Inc.

SESN

Full Analysis

Annual Balance Sheets
AlphaTime Acquisition Corp

ATMCW

Full Analysis

Annual Balance Sheets
Xiamen Changelight Co., Ltd.

300102

Full Analysis

Annual Balance Sheets
P2 Solar, Inc

PTOS

Full Analysis

Annual Balance Sheets
CervoMed Inc.

CRVO

Full Analysis

Annual Balance Sheets

Global Stocks Search

CARGO Therapeutics, Inc. Common Stock (CRGX)

Annual Balance Sheets

Balance Sheet Charts

Hexima Limited

Sesen Bio, Inc.

AlphaTime Acquisition Corp

Xiamen Changelight Co., Ltd.

P2 Solar, Inc

CervoMed Inc.